Cargando…
Preliminary evidence of safety and effectiveness of Loxoprofen Sodium Cataplasm combined with physiotherapy for myofascial pain syndrome treatment: A randomized controlled pilot clinical trial
BACKGROUND: Myofascial pain syndrome (MPS) is one of the most common causes of chronic skeletal muscle pain, which is closely related to skeletal muscle myofascial trigger point (MTRP). Since there is no first-line treatment for MPS, we investigated Loxoprofen Sodium Cataplasm combined with physioth...
Autores principales: | Zhou, Xuewen, Li, Xuelian, Wang, Ziyang, Huang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724624/ https://www.ncbi.nlm.nih.gov/pubmed/36484021 http://dx.doi.org/10.3389/fneur.2022.998327 |
Ejemplares similares
-
Efficacy and safety of flurbiprofen cataplasms versus loxoprofen sodium cataplasms in knee osteoarthritis: a randomized controlled trial
por: Li, Dong, et al.
Publicado: (2023) -
The Philosophy of Cataplasms
Publicado: (1870) -
Safety and efficacy of skin patches containing loxoprofen sodium in diabetic patients with overt nephropathy
por: Araki, Hisazumi, et al.
Publicado: (2013) -
Mr. Bethune, on the Use of Mustard Cataplasm
por: Bethune, J.
Publicado: (1805) -
Topical Delivery of Ketorolac Tromethamine via Cataplasm for Inflammatory Pain Therapy
por: Hou, Zhiyuan, et al.
Publicado: (2023)